View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Steatohepatitis/Metabolic Liver Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
February 19, 2024
4 min read
Save

MASLD requires multidisciplinary care to ‘improve global metabolic, liver health’

MASLD requires multidisciplinary care to ‘improve global metabolic, liver health’

Finding adequate providers with the expertise to treat the growing population of patients with chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease, is a challenging but important endeavor.

SPONSORED CONTENT
February 19, 2024
2 min read
Save

Early intervention critical, before ‘significant clinical toll’ from excessive alcohol use

Early intervention critical, before ‘significant clinical toll’ from excessive alcohol use

Alcohol use disorder has a huge impact on liver health. Regardless of whether patients have other primary etiology for liver disease, alcohol — even in minimal amounts — can worsen liver outcomes.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
February 15, 2024
2 min read
Save

GLP1s may lower 10-year risk for major adverse outcomes in chronic liver disease, diabetes

GLP1s may lower 10-year risk for major adverse outcomes in chronic liver disease, diabetes

Adherence to treatment with glucagon-like peptide-1 receptor agonists may lower the long-term risk for major adverse liver outcomes among patients with chronic liver disease and type 2 diabetes, according to data in Gut.

SPONSORED CONTENT
February 15, 2024
1 min read
Save

FDA grants 510(k) clearance to Nanox AI software to assess ‘early signs’ of fatty liver

FDA grants 510(k) clearance to Nanox AI software to assess ‘early signs’ of fatty liver

The FDA has granted 510(k) clearance to Nanox’s HealthFLD artificial intelligence software to aid clinicians in the detection of fatty liver associated with hepatic steatosis, according to a company press release.

SPONSORED CONTENT
February 13, 2024
2 min read
Save

Liver disease, frequency of alcohol-related care linked to mortality, hospital readmission

Liver disease, frequency of alcohol-related care linked to mortality, hospital readmission

Individuals with alcohol-related liver disease and frequent health care utilization were at greater risk for mortality and hospital readmission, respectively, according to a cohort study of alcohol-related hospitalizations in Canada.

SPONSORED CONTENT
February 13, 2024
2 min read
Save

Women with concurrent MASLD, alcohol-related liver disease have 83% higher risk for death

Women with concurrent MASLD, alcohol-related liver disease have 83% higher risk for death

Women with concurrent metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease had an 83% greater risk for all-cause mortality than men and those with ALD alone had 160% greater risk, data showed.

SPONSORED CONTENT
February 05, 2024
1 min read
Save

Chronic HBV ‘positively associates’ with severe necroinflammation in pediatric MASLD

Chronic HBV ‘positively associates’ with severe necroinflammation in pediatric MASLD

Chronic hepatitis B virus infection was positively linked with severe hepatic necroinflammation in children with metabolic dysfunction-associated steatotic liver disease but did not appear to affect hepatic fibrosis, according to data.

SPONSORED CONTENT
February 01, 2024
1 min read
Save

Atopic dermatitis in children may be linked to metabolic syndrome, liver disease

Atopic dermatitis in children may be linked to metabolic syndrome, liver disease

Atopic dermatitis in children may be associated with metabolic syndrome and nonalcoholic fatty liver disease, according to a study.

SPONSORED CONTENT
January 25, 2024
2 min read
Save

FASCINATE-2 topline data: Denifanstat surpasses placebo for NASH with fibrosis at week 52

FASCINATE-2 topline data: Denifanstat surpasses placebo for NASH with fibrosis at week 52

Topline data from the phase 2b FASCINATE-2 trial showed “statistically significant improvement” for denifanstat in biopsy-confirmed nonalcoholic steatohepatitis with stage 2 or stage 3 fibrosis at 52 weeks, Sagimet Biosciences announced.

SPONSORED CONTENT
January 23, 2024
2 min read
Save

Liver fibrosis screening linked to lifestyle changes in individuals at risk for ALD, MASLD

Liver fibrosis screening linked to lifestyle changes in individuals at risk for ALD, MASLD

Screening for liver fibrosis was associated with improved self-reported alcohol consumption, diet, exercise and weight after 6 months among patients at risk for liver disease, with lifestyle changes persisting through 2 years.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails